Vestibular Neuronitis
7
1
1
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
28.6%
2 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
Acute Unilateral Vestibulopathy and Corticosteroid Treatment
Recovery of Visual Acuity in People With Vestibular Deficits
Home-based Computer Gaming in Vestibular Rehabilitation
Prednisone Treatment for Vestibular Neuronitis
Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System